PerkinElmer, Corning to Develop Label-Free Screening Tech | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer and Corning will collaborate to develop label-free detection technologies for the drug discovery market, Corning said today.

Under the agreement, the companies will combine Corning's optical label-free detection technology with PerkinElmer's multi-label detection systems to offer next-generation drug discovery platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.